Piboserod
Piboserod is a selective 5-HT4 receptor antagonist which was marketed and manufactured by Novartis for the management of irritable bowel syndrome and other gastrointestinal disorders. However, it was withdrawn from the market due to concerns about serious cardiovascular side effects.
Etymology[edit | edit source]
The term "Piboserod" is a coined name, with no specific etymology. It is a synthetic compound and its name is derived from its chemical structure.
Pharmacology[edit | edit source]
Piboserod works by blocking the action of the neurotransmitter serotonin at the 5-HT4 receptor. Serotonin is a chemical that is involved in the regulation of the gut's motility and sensitivity. By blocking the action of serotonin, Piboserod can help to regulate the movement of the gut and reduce the symptoms of irritable bowel syndrome.
Clinical Use[edit | edit source]
Piboserod was used for the treatment of irritable bowel syndrome (IBS) in women who have constipation as their main symptom. It was also used for the treatment of chronic constipation in men and women under certain circumstances.
Side Effects[edit | edit source]
The use of Piboserod has been associated with a number of side effects. The most common side effects include headache, abdominal pain, and diarrhea. However, the drug was withdrawn from the market due to concerns about serious cardiovascular side effects, including heart attacks and strokes.
Withdrawal from Market[edit | edit source]
In 2007, Novartis withdrew Piboserod from the market after a review of clinical trial data showed an increased risk of serious cardiovascular side effects. The decision to withdraw the drug was made in consultation with regulatory authorities.
See Also[edit | edit source]
Piboserod Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD